BioCentury
ARTICLE | Clinical News

Liposome Tech regulatory update

October 17, 1994 7:00 AM UTC

Liposome Technology Inc. (LTIZ) LTIZ (Menlo Park, Calif.) received approval in Ireland for its Amphocil liposomal formulation of amphotericin B to treat systemic fungal infections in cases where toxi...